Please Wait

Applying Filters...

Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Triamcinolone Hexacetonide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 5 USDMF, 2 CEP/COS, 1 EU WC, 2 NDC API, 9 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

14 FDF Dossiers, 2 FDA Orange Book, 10 Europe, 1 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 1 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 4 Actylis, 1 BASF, 1 Finar, 3 Gangwal Chemicals, 1 Nanjing Bold Chemical, 11 Roquette, 6 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

11 Solubilizers, 11 Film Formers & Plasticizers, 10 Parenteral, 5 Topical, 4 Taste Masking, 4 Coating Systems & Additives, 4 Fillers, Diluents & Binders, 3 Surfactant & Foaming Agents, 3 Emulsifying Agents, 2 Thickeners and Stabilizers, 2 Direct Compression, 2 Co-Processed Excipients, 2 Chewable & Orodispersible Aids, 1 API Stability Enhancers, 1 Soft Gelatin, 1 Rheology Modifiers

MARKET PLACE

1 APIs

1 APIs

$ Xls download

Filters

Log in to download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
31/10/2025	Coral Drugs Private Limited	India	CORAL DRUGS PRIVATE LTD	37346	TRIAMCINOLONE HEXACETONIDE	2022-08-04	Active	II	N/A
31/10/2025	Axplora	Germany	FARMABIOS SPA	17758	TRIAMCINOLONE HEXACETONIDE	2004-10-15	Active	II	N/A

Contact us
to update this info

Triamcinolone Hexacetonide

Triamcinolone Hexacetonide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers

5 USDMF

2 CEP/COS

1 EU WC

2 NDC API

9 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

14 FDF Dossiers

2 FDA Orange Book

10 Europe

1 Canada

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

2 SPI Pharma

1 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Kirsch Pharma

4 Actylis

1 BASF

1 Finar

3 Gangwal Chemicals

1 Nanjing Bold Chemical

11 Roquette

6 Seppic

1 Shijiazhuang Huaxu Pharmaceutical

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

11 Solubilizers

11 Film Formers & Plasticizers

10 Parenteral

5 Topical

4 Taste Masking

4 Coating Systems & Additives

4 Fillers, Diluents & Binders

3 Surfactant & Foaming Agents

3 Emulsifying Agents

2 Thickeners and Stabilizers

2 Direct Compression

2 Co-Processed Excipients

2 Chewable & Orodispersible Aids

1 API Stability Enhancers

1 Soft Gelatin

1 Rheology Modifiers

MARKET PLACE

1 APIs

Filters

INJECTABLE;INJECTION - 20MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons